Human Cytochrome P450 Family 4 Enzymes: Function, Genetic Variation and Regulation

REFERENCES

• Al-Anizy M., Horley N. J., Kuo C. W., Gillett L. C., Laughton C. A., Kendall D., Barrett D. A., Parker T., Bell D. R. Cytochrome P450 Cyp4x1 is a major P450 protein in mouse brain. FEBS J. 2006; 273: 936–947
   PubMed Web of Science ®Google Scholar
• Alterman M. A., Chaurasia C. S., Lu P., Hardwick J. P., Hanzlik R. P. Fatty acid discrimination and omega-hydroxylation by cytochrome P450 4A1 and a cytochrome P4504A1/NADPH-P450 reductase fusion protein. Arch. Biochem. Biophys. 1995; 320: 289–296
   PubMed Web of Science ®Google Scholar
• Antoun J., Amet Y., Simon B., Dreano Y., Corlu A., Corcos L., Salaun J. P., Plee-Gautier E. CYP4A11 is repressed by retinoic acid in human liver cells. FEBS Lett. 2006; 580: 3361–3367
   PubMed Web of Science ®Google Scholar
• Baer B. R., Rettie A. E. CYP4B1: an enigmatic P450 at the interface between xenobiotic and endobiotic metabolism. Drug Metab Rev. 2006; 38: 451–476
   PubMed Web of Science ®Google Scholar
• Baker J. R., Satarug S., Edwards R. J., Moore M. R., Williams D. J., Reilly P. E. Potential for early involvement of CYP isoforms in aspects of human cadmium toxicity. Toxicol. Lett. 2003; 137: 85–93
   PubMed Web of Science ®Google Scholar
• Bellamine A., Wang Y., Waterman M. R., Gainer J. V., III, Dawson E. P., Brown N. J., Capdevila J. H. Characterization of the CYP4A11 gene, a second CYP4A gene in humans. Arch. Biochem. Biophys. 2003; 409: 221–227
   PubMed Web of Science ®Google Scholar
• Bylund J., Bylund M., Oliw E. H. cDNA Cloning and Expression of CYP4F12, a Novel Human Cytochrome P450. Biochem. Biophys. Res. Commun. 2001; 280: 892–897
   PubMed Web of Science ®Google Scholar
• Bylund J., Harder A. G., Maier K. G., Roman R. J., Harder D. R. Leukotriene B4 omega-side chain hydroxylation by CYP4F5 and CYP4F6. Arch. Biochem. Biophys. 2003; 412: 34–41
   PubMed Web of Science ®Google Scholar
• Bylund J., Hidestrand M., Ingelman-Sundberg M., Oliw E. H. Identification of CYP4F8 in human seminal vesicles as a prominent 19-hydroxylase of prostaglandin endoperoxides. J. Biol. Chem. 2000; 275: 21844–21849
   PubMed Web of Science ®Google Scholar
• Bylund J., Zhang C., Harder D. Identification of a novel cytochrome P450, CYP4X1, with unique localization specific to the brain. Biochem. Biophys. Res. Commun. 2002; 296: 677–684
   PubMed Web of Science ®Google Scholar
• Capdevila J. H., Falck J. R. The CYP P450 arachidonic acid monooxygenases: from cell signaling to blood pressure regulation. Biochem. Biophys. Res. Commun. 2001; 285: 571–576
   PubMed Web of Science ®Google Scholar
• Capdevila J. H., Falck J. R., Harris R. C. Cytochrome P450 and arachidonic acid bioactivation. Molecular and functional properties of the arachidonate monooxygenase. J. Lipid Res. 2000; 41: 163–181
   PubMed Web of Science ®Google Scholar
• Chen L., Hardwick J. P. Identification of a new P450 subfamily, CYP4F1, expressed in rat hepatic tumors. Arch. Biochem. Biophys. 1993; 300: 18–23
   PubMed Web of Science ®Google Scholar
• Cheung C., Akiyama T. E., Ward J. M., Nicol C. J., Feigenbaum L., Vinson C., Gonzalez F. J. Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor alpha. Cancer Res. 2004; 64: 3849–3854
   PubMed Web of Science ®Google Scholar
• Choudhary D., Jansson I., Stoilov I., Sarfarazi M., Schenkman J. B. Expression patterns of mouse and human CYP orthologs (families 1–4) during development and in different adult tissues. Arch. Biochem. Biophys. 2005; 436: 50–61
   PubMed Web of Science ®Google Scholar
• Christmas P., Jones J. P., Patten C. J., Rock D. A., Zheng Y., Cheng S. M., Weber B. M., Carlesso N., Scadden D. T., Rettie A. E., Soberman R. J. Alternative splicing determines the function of CYP4F3 by switching substrate specificity. J. Biol. Chem. 2001; 276: 38166–38172
   PubMed Web of Science ®Google Scholar
• Christmas P., Tolentino K., Primo V., Berry K. Z., Murphy R. C., Chen M., Lee D. M., Soberman R. J. Cytochrome P-450 4F18 is the leukotriene B4 omega-1/omega-2 hydroxylase in mouse polymorphonuclear leukocytes: identification as the functional orthologue of human polymorphonuclear leukocyte CYP4F3A in the down-regulation of responses to LTB4. J. Biol. Chem. 2006; 281: 7189–7196
   PubMed Web of Science ®Google Scholar
• Christmas P., Ursino S. R., Fox J. W., Soberman R. J. Expression of the CYP4F3 gene. tissue-specific splicing and alternative promoters generate high and low k(m) forms of leukotriene b(4) omega- hydroxylase. J. Biol. Chem. 1999; 274: 21191–21199
   PubMed Web of Science ®Google Scholar
• Clancy R. M., Dahinden C. A., Hugli T. E. Oxidation of leukotrienes at the w end: Demonstration of a receptor for the 20-hydroxy derivative of leukotriene B4 on human neutrophils and implications for the analysis of leukotriene receptors. Proc. Natl. Acad. Sci. 1984; 81: 5729–5733
   PubMed Web of Science ®Google Scholar
• Cornwell P. D., De Souza A. T., Ulrich R. G. Profiling of hepatic gene expression in rats treated with fibric acid analogs. Mutat. Res. 2004; 549: 131–145
   PubMed Web of Science ®Google Scholar
• Corton J. C., Apte U., Anderson S. P., Limaye P., Yoon L., Latendresse J., Dunn C., Everitt J. I., Voss K. A., Swanson C., Kimbrough C., Wong J. S., Gill S. S., Chandraratna R. A., Kwak M. K., Kensler T. W., Stulnig T. M., Steffensen K. R., Gustafsson J. A., Mehendale H. M. Mimetics of Caloric Restriction Include Agonists of Lipid-activated Nuclear Receptors. J. Biol. Chem. 2004; 279: 46204–46212
   PubMed Web of Science ®Google Scholar
• Cowart L. A., Wei S., Hsu M. H., Johnson E. F., Krishna M. U., Falck J. R., Capdevila J. H. The CYP4A isoforms hydroxylate epoxyeicosatrienoic acids to form high affinity peroxisome proliferator-activated receptor ligands. J. Biol. Chem. 2002; 277: 35105–35112
   PubMed Web of Science ®Google Scholar
• Davies G. F., Khandelwal R. L., Roesler W. J. Troglitazone inhibits expression of the phosphoenolpyruvate carboxykinase gene by an insulin-independent mechanism. Biochim. Biophys. Acta 1999; 1451: 122–131
   PubMed Web of Science ®Google Scholar
• Demoz A., Vaagenes H., Aarsaether N., Hvattum E., Skorve J., Göttlicher M., Lillehaug J. R., Gibson G. G., Gustafsson J.Å., Hood S., Berge R. K. Coordinate induction of hepatic fatty acyl-CoA oxidase and P4504A1 in rat after activation of the peroxisome proliferator activated receptor (PPAR) by sulphur-substituted fatty acid analogues. Xenobiotica. 1994; 24: 943–956
   PubMed Web of Science ®Google Scholar
• Downie D., McFadyen M. C., Rooney P. H., Cruickshank M. E., Parkin D. E., Miller I. D., Telfer C., Melvin W. T., Murray G. I. Profiling cytochrome P450 expression in ovarian cancer: identification of prognostic markers. Clin. Cancer Res. 2005; 11: 7369–7375
   PubMed Web of Science ®Google Scholar
• Fang X., Hu S., Xu B., Snyder G. D., Harmon S., Yao J., Liu Y., Sangras B., Falck J. R., Weintraub N. L., Spector A. A. 14,15-Dihydroxyeicosatrienoic acid activates peroxisome proliferator-activated receptor-alpha. Am. J. Physiol Heart Circ. Physiol. 2006; 290: H55–H63
   PubMed Web of Science ®Google Scholar
• Gainer J. V., Bellamine A., Dawson E. P., Womble K. E., Grant S. W., Wang Y., Cupples L. A., Guo C. Y., Demissie S., O'Donnell C. J., Brown N. J., Waterman M. R., Capdevila J. H. Functional variant of CYP4A11 20-hydroxyeicosatetraenoic acid synthase is associated with essential hypertension. Circulation. 2005; 111: 63–69
   PubMed Web of Science ®Google Scholar
• Gasser R., Philpot R. M. Primary structures of cytochrome P-450 isozyme 5 from rabbit and rat and regulation of species-dependent expression and induction in lung and liver: Identification of cytochrome P-450 gene subfamily IVB. Mol. Pharmacol. 1989; 35: 617–625
   PubMed Web of Science ®Google Scholar
• Gekka T., Hayashi T., Takeuchi T., Goto-Omoto S., Kitahara K. CYP4V2 mutations in two Japanese patients with Bietti's crystalline dystrophy. Ophthalmic Res. 2005; 37: 262–269
   PubMed Web of Science ®Google Scholar
• Gibson G. G., Orton T. C., Tamburini P. P. Cytochrome P-450 induction by clofibrate. Biochem. J. 1982; 203: 161–168
   PubMed Web of Science ®Google Scholar
• Goldstein J. L., Bose-Boyd R. A., Brown M. S. Protein sensors for membrane sterols. Cell. 2006; 124: 35–46
   PubMed Web of Science ®Google Scholar
• Hacein-Bey L., Harder D. R., Meier H. T., Varelas P. N., Miyata N., Lauer K. K., Cusick J. F., Roman R. J. Reversal of delayed vasospasm by TS-011 in the dual hemorrhage dog model of subarachnoid hemorrhage. AJNR Am. J. Neuroradiol. 2006; 27: 1350–1354
   PubMed Web of Science ®Google Scholar
• Hardwick J. P., Song B. J., Huberman E., Gonzalez F. J. Isolation, complementary DNA sequence, and regulation of rat hepatic lauric acid omega-hydroxylase (cytochrome P-450LAomega). J. Biol. Chem. 1987; 262: 801–810
   PubMed Web of Science ®Google Scholar
• Hashizume T., Imaoka S., Hiroi T., Terauchi Y., Fujii T., Miyazaki H., Kamataki T., Funae Y. cDNA Cloning and Expression of a Novel Cytochrome P450 (CYP4F12) from Human Small Intestine. Biochem. Biophys. Res. Commun. 2001; 280: 1135–1141
   PubMed Web of Science ®Google Scholar
• Helvig C., Dishman E., Capdevila J. H. Molecular, Enzymatic, and Regulatory Characterization of Rat Kidney Cytochromes P450 4A2 and 4A3. Biochemistry. 1998; 37: 12546–12558
   PubMed Web of Science ®Google Scholar
• Hiratsuka M., Nozawa H., Katsumoto Y., Moteki T., Sasaki T., Konno Y., Mizugaki M. Genetic polymorphisms and haplotype structures of the CYP4A22 gene in a Japanese population. Mutat. Res. 2006; 599: 98–104
   PubMed Web of Science ®Google Scholar
• Hoch U., Zhang Z., Kroetz D. L., Ortiz de Montellano P. R. Structural determination of the substrate specificities and regioselectivities of the rat and human fatty acid omega-hydroxylases. Arch. Biochem. Biophys. 2000; 373: 63–71
   PubMed Web of Science ®Google Scholar
• Holla V. R., Adas F., Imig J. D., Zhao X., Price E., Jr., Olsen N., Kovacs W. J., Magnuson M. A., Keeney D. S., Breyer M. D., Falck J. R., Waterman M. R., Capdevila J. H. Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension. Proc. Natl. Acad. Sci. USA 2001; 98: 5211–5216
   PubMed Web of Science ®Google Scholar
• Horton J. D., Shah N. A., Warrington J. A., Anderson N. N., Park S. W., Brown M. S., Goldstein J. L. Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. Proc. Natl. Acad. Sci. USA 2003; 100: 12027–12032
   PubMed Web of Science ®Google Scholar
• Hsu M. H., Savas U., Griffin K. J., Johnson E. F. Identification of peroxisome proliferator responsive human genes by elevated expression of the peroxisome proliferator activated receptor alpha (PPARα) in HepG2 Cells. J. Biol. Chem. 2001; 276: 27950–27958
   PubMed Web of Science ®Google Scholar
• Hsu M. H., Savas U., Griffin K. J., Johnson E. F. Regulation of human cytochrome P450 4F2 expression by sterol regulatory element-binding protein and lovastatin. J. Biol. Chem. 2007; 282: 5225–5236
   PubMed Web of Science ®Google Scholar
• Imaoka S., Hayashi K., Hiroi T., Yabusaki Y., Kamataki T., Funae Y. A transgenic mouse expressing human CYP4B1 in the liver. Biochem. Biophys. Res. Commun. 2001; 284: 757–762
   PubMed Web of Science ®Google Scholar
• Ito O., Nakamura Y., Tan L., Ishizuka T., Sasaki Y., Minami N., Kanazawa M., Ito S., Sasano H., Kohzuki M. Expression of cytochrome P-450 4 enzymes in the kidney and liver: Regulation by PPAR and species-difference between rat and human. Mol. Cell Biochem. 2006; 284: 141–148
   PubMed Web of Science ®Google Scholar
• Jin Z. B., Ito S., Saito Y., Inoue Y., Yanagi Y., Nao-i N. Clinical and molecular findings in three Japanese patients with crystalline retinopathy. Jpn. J. Ophthalmol. 2006; 50: 426–431
   PubMed Web of Science ®Google Scholar
• Johnson E. F., Hsu M. H., Savas U., Griffin K. J. Regulation of P450 4A expression by peroxisome proliferator activated receptors. Toxicology. 2002; 181–182: 203–206
   PubMed Web of Science ®Google Scholar
• Kalsotra A., Anakk S., Boehme C. L., Strobel H. W. Sexual dimorphism and tissue specificity in the expression of CYP4F forms in Sprague Dawley rats. Drug Metabol Dispos. 2002; 30: 1022–1028
   PubMed Web of Science ®Google Scholar
• Kalsotra A., Cui X., Anakk S., Hinojos C. A., Doris P. A., Strobel H. W. Renal localization, expression, and developmental regulation of P450 4F cytochromes in three substrains of spontaneously hypertensive rats. Biochem. Biophys. Res. Commun. 2005; 338: 423–431
   PubMed Web of Science ®Google Scholar
• Kalsotra A., Cui X., Antonovic L., Robida A. M., Morgan E. T., Strobel H. W. Inflammatory prompts produce isoform-specific changes in the expression of leukotriene B(4) omega-hydroxylases in rat liver and kidney. FEBS Lett. 2003; 555: 236–242
   PubMed Web of Science ®Google Scholar
• Kalsotra A., Strobel H. W. Cytochrome P450 4F subfamily: at the crossroads of eicosanoid and drug metabolism. Pharmacol. Ther. 2006; 112: 589–611
   PubMed Web of Science ®Google Scholar
• Kalsotra A., Turman C. M., Kikuta Y., Strobel H. W. Expression and characterization of human cytochrome P450 4F11: Putative role in the metabolism of therapeutic drugs and eicosanoids. Toxicol. Appl. Pharmacol. 2004; 199: 295–304
   PubMed Web of Science ®Google Scholar
• Kawashima H., Naganuma T., Kusunose E., Kono T., Yasumoto R., Sugimura K., Kishimoto T. Human fatty acid omega-hydroxylase, CYP4A11: determination of complete genomic sequence and characterization of purified recombinant protein. Arch. Biochem. Biophys. 2000; 378: 333–339
   PubMed Web of Science ®Google Scholar
• Kikuta Y., Kasyu H., Kusunose E., Kusunose M. Expression and catalytic activity of mouse leukotriene B4 omega-hydroxylase, CYP4F14. Arch. Biochem. Biophys. 2000; 383: 225–232
   PubMed Web of Science ®Google Scholar
• Kikuta Y., Kusunose E., Endo K., Yamamoto S., Sogawa K., Fujii-Kuriyama Y., Kusunose M. A novel form of cytochrome P-450 family 4 in human polymorphonuclear leukocytes. cDNA cloning and expression of leukotriene B4 omega-hydroxylase. J. Biol. Chem. 1993; 268: 9376–9380
   PubMed Web of Science ®Google Scholar
• Kikuta Y., Yamashita Y., Kashiwagi S., Tani K., Okada K., Nakata K. Expression and induction of CYP4F subfamily in human leukocytes and HL60 cells. Biochim. Biophys. Acta. 2004; 1683: 7–15
   PubMed Web of Science ®Google Scholar
• Kocarek T. A., Reddy A. B. Regulation of cytochrome P450 expression by inhibitors of hydroxymethylglutaryl-coenzyme A reductase in primary cultured rat hepatocytes and in rat liver. Drug Metabol Dispos. 1996; 24: 1197–1204
   PubMed Web of Science ®Google Scholar
• Komen J. C., Duran M., Wanders R. J. Characterization of phytanic acid omega-hydroxylation in human liver microsomes. Mol. Genet. Metab. 2005; 85: 190–195
   PubMed Web of Science ®Google Scholar
• Komen J. C., Duran M., Wanders R. J. {omega}-Hydroxylation of phytanic acid in rat liver microsomes: Implications for Refsum disease. J. Lipid Res. 2004; 45: 1341–1346
   PubMed Web of Science ®Google Scholar
• Komen J. C., Wanders R. J. Identification of the cytochrome P450 enzymes responsible for the omega-hydroxylation of phytanic acid. FEBS Lett. 2006; 580: 3794–3798
   PubMed Web of Science ®Google Scholar
• Kroetz D. L., Yook P., Costet P., Bianchi P., Pineau T. Peroxisome proliferatoractivated receptor alpha controls the hepatic CYP4A induction adaptive response to starvation and diabetes. J. Biol. Chem. 1998; 273: 31581–31589
   PubMed Web of Science ®Google Scholar
• Lasker J. M., Chen W. B., Wolf I., Bloswick B. P., Wilson P. D., Powell P. K. Formation of 20-hydroxyeicosatetraenoic acid, a vasoactive and natriuretic eicosanoid, in human kidney. Role of Cyp4F2 and Cyp4A11. J. Biol. Chem. 2000; 275: 4118–4126
   PubMed Web of Science ®Google Scholar
• Lawrence J. W., Li Y., Chen S., DeLuca J. G., Berger J. P., Umbenhauer D. R., Moller D. E., Zhou G. Differential gene regulation in human versus rodent hepatocytes by peroxisome proliferator-activated receptor (PPAR) alpha. PPAR alpha fails to induce peroxisome proliferation-associated genes in human cells independently of the level of receptor expresson. J. Biol. Chem. 2001; 276: 31521–31527
   PubMed Web of Science ®Google Scholar
• Lee J., Jiao X., Hejtmancik J. F., Kaiser-Kupfer M., Chader G. J. Identification, isolation, and characterization of a 32-kDa fatty acid-binding protein missing from lymphocytes in humans with Bietti crystalline dystrophy (BCD). Mol. Genet. Metab. 1998; 65: 143–154
   PubMed Web of Science ®Google Scholar
• Lee K. Y., Koh A. H., Aung T., Yong V. H., Yeung K., Ang C. L., Vithana E. N. Characterization of Bietti crystalline dystrophy patients with CYP4V2 mutations. Invest Ophthalmol. Vis. Sci. 2005; 46: 3812–3816
   PubMed Web of Science ®Google Scholar
• Lee S. S. T., Pineau T., Drago J., Lee E. J., Owens J. W., Kroetz D. L., Fernandez-Salguero P. M., Westphal H., Gonzalez F. J. Targeted disruption of the α isoform of the peroxisome proliferator activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell. Biol. 1995; 15: 3012–3022
   PubMed Web of Science ®Google Scholar
• Lefevre C., Bouadjar B., Ferrand V., Tadini G., Megarbane A., Lathrop M., Prud'homme J. F., Fischer J. Mutations in a new cytochrome P450 gene in lamellar ichthyosis type 3. Hum. Mol. Genet. 2006; 15: 767–776
   PubMed Web of Science ®Google Scholar
• Li A., Jiao X., Munier F. L., Schorderet D. F., Yao W., Iwata F., Hayakawa M., Kanai A., Shy C. M., Alan L. R., Heckenlively J., Weleber R. G., Traboulsi E. I., Zhang Q., Xiao X., Kaiser-Kupfer M., Sergeev Y. V., Hejtmancik J. F. Bietti crystalline corneoretinal dystrophy is caused by mutations in the novel gene CYP4V2. Am. J. Hum. Genet. 2004; 74: 817–826
   PubMed Web of Science ®Google Scholar
• Lin J., Nishiguchi K. M., Nakamura M., Dryja T. P., Berson E. L., Miyake Y. Recessive mutations in the CYP4V2 gene in East Asian and Middle Eastern patients with Bietti crystalline corneoretinal dystrophy. J. Med. Genet. 2005; 42: e38
   PubMed Web of Science ®Google Scholar
• Liu H., Zhao Y. Y., Gong W., Shi J. P., Fu L. Y., Wang J., Li G. Y., Lu J. Y. Correlation analysis and identification of G421C in regulatory region of CYP4F2 gene with essential hypertension. Zhongguo Yi.Xue.Ke.Xue.Yuan Xue.Bao. 2006; 28: 143–147
   PubMedGoogle Scholar
• Lu A. Y. H., Coon M. J. Role of hemoprotein P-450 in fatty acid ω-hydroxylation in a soluble enzyme system from liver microsomes. J. Biol. Chem. 1968; 243: 1331–1332
   PubMed Web of Science ®Google Scholar
• Lu A. Y. H., Junk K. W., Coon M. J. Resolution of the cytochrome P-450containing ω‐hydroxylation system of liver microsomes into three components. J. Biol. Chem. 1969; 244: 3714–3721
   PubMed Web of Science ®Google Scholar
• Mayer B., Lieb W., Gotz A., Konig I. R., Aherrahrou Z., Thiemig A., Holmer S., Hengstenberg C., Doering A., Loewel H., Hense H. W., Schunkert H., Erdmann J. Association of the T8590C polymorphism of CYP4A11 with hypertension in the MONICA Augsburg echocardiographic substudy. Hypertension. 2005; 46: 766–771
   PubMed Web of Science ®Google Scholar
• Mayer B., Lieb W., Gotz A., Konig I. R., Kauschen L. F., Linsel-Nitschke P., Pomarino A., Holmer S., Hengstenberg C., Doering A., Loewel H., Hense H. W., Ziegler A., Erdmann J., Schunkert H. Association of a functional polymorphism in the CYP4A11 gene with systolic blood pressure in survivors of myocardial infarction. J.Hypertens. 2006; 24: 1965–1970
   PubMed Web of Science ®Google Scholar
• Miyata N., Seki T., Tanaka Y., Omura T., Taniguchi K., Doi M., Bandou K., Kametani S., Sato M., Okuyama S., Cambj-Sapunar L., Harder D. R., Roman R. J. Beneficial effects of a new 20-hydroxyeicosatetraenoic acid synthesis inhibitor, TS-011 [N-(3-chloro-4-morpholin-4-yl) phenyl-N'-hydroxyimido formamide], on hemorrhagic and ischemic stroke. J. Pharmacol. Exp. Ther. 2005; 314: 77–85
   PubMed Web of Science ®Google Scholar
• Morimura K., Cheung C., Ward J. M., Reddy J. K., Gonzalez F. J. Differential susceptibility of mice humanized for peroxisome proliferator-activated receptor alpha to Wy-14,643-induced liver tumorigenesis. Carcinogenesis. 2006; 27: 1074–1080
   PubMed Web of Science ®Google Scholar
• Mortensen P. B. Formation and degradation of dicarboxylic acids in relation to alterations in fatty acid oxidation in rats. Biochim. Biophys. Acta 1992; 1124: 71–79
   PubMed Web of Science ®Google Scholar
• Muerhoff A. S., Griffin K. J., Johnson E. F. The peroxisome proliferator activated receptor mediates the induction of CYP4A6, a cytochrome P450 fatty acid omega-hydroxylase, by clofibric acid. J. Biol. Chem. 1992; 267: 19051–19053
   PubMed Web of Science ®Google Scholar
• Muller D. N., Schmidt C., Barbosa-Sicard E., Wellner M., Gross V., Hercule H., Markovic M., Honeck H., Luft F. C., Schunck W. H. Mouse Cyp4a isoforms: enzymatic properties, gender- and strain-specific expression, and role in renal 20hydroxyeicosatetraenoic acid formation. Biochem. J. 2006; 403: 109–118
   Web of Science ®Google Scholar
• Nakagawa K., Holla V. R., Wei Y., Wang W. H., Gatica A., Wei S., Mei S., Miller C. M., Cha D. R., Price E., Zent R., Pozzi A., Breyer M. D., Guan Y., Falck J. R., Waterman M. R., Capdevila J. H. Salt-sensitive hypertension is associated with dysfunctional Cyp4a10 gene and kidney epithelial sodium channel. J. Clin. Invest. 2006; 116: 1696–1702
   PubMed Web of Science ®Google Scholar
• Nakamura M., Lin J., Nishiguchi K., Kondo M., Sugita J., Miyake Y. Bietti crystalline corneoretinal dystrophy associated with CYP4V2 gene mutations. Adv. Exp. Med. Biol. 2006; 572: 49–53
   PubMed Web of Science ®Google Scholar
• Nelson D. R. Gene nomenclature by default, or BLASTing to Babel. Hum. Genomics. 2005; 2: 196–201
   PubMedGoogle Scholar
• Nelson D. R., Zeldin D. C., Hoffman S. M., Maltais L. J., Wain H. M., Nebert D. W. Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. Pharmacogenetics. 2004; 14: 1–18
   PubMedGoogle Scholar
• Ng V. Y., Huang Y., Reddy L. M., Falck J. R., Lin E. T., Kroetz D. L. Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor alpha (PPARα). Drug Metabol Dispos. 2007; 35: 1126–1134
   PubMed Web of Science ®Google Scholar
• Okita R. T., Okita J. R. Cytochrome P450 4A fatty acid omega hydroxylases. Curr.Drug Metabol 2001; 2: 265–281
   PubMed Web of Science ®Google Scholar
• Omura T., Tanaka Y., Miyata N., Koizumi C., Sakurai T., Fukasawa M., Hachiuma K., Minagawa T., Susumu T., Yoshida S., Nakaike S., Okuyama S., Harder D. R., Roman R. J. Effect of a new inhibitor of the synthesis of 20-HETE on cerebral ischemia reperfusion injury. Stroke. 2006; 37: 1307–1313
   PubMed Web of Science ®Google Scholar
• Orton T. C., Parker G. L. The effect of hypolipidemic agents on the hepatic microsomal drug-metabolizing enzyme system of the rat. Induction of cytochrome(s) P450 with specificity toward terminal hydroxylation of lauric acid. Drug Metabol Dispos. 1982; 10: 110–115
   PubMed Web of Science ®Google Scholar
• Palmer C. N. A., Richardson T. H., Griffin K. J., Hsu M.-H., Muerhoff A. S., Clark J. E., Johnson E. F. Characterization of a cDNA encoding a human kidney, cytochrome P-450 4A fatty acid omega-hydroxylase and the cognate enzyme expressed in Escherichia coli. Biochim. Biophys. Acta Gene Struct. Expr. 1993; 1172: 161–166
   PubMed Web of Science ®Google Scholar
• Powell P. K., Wolf I., Jin R., Lasker J. M. Metabolism of arachidonic acid to 20hydroxy-5,8,11, 14-eicosatetraenoic acid by P450 enzymes in human liver: involvement of CYP4F2 and CYP4A11. J. Pharmacol. Exp. Ther. 1998; 285: 1327–1336
   PubMed Web of Science ®Google Scholar
• Powell P. K., Wolf I., Lasker J. M. Identification of CYP4A11 as the major lauric acid omega-hydroxylase in human liver microsomes. Arch. Biochem. Biophys. 1996; 335: 219–226
   PubMed Web of Science ®Google Scholar
• Pujol A., Hindelang C., Callizot N., Bartsch U., Schachner M., Mandel J. L. Late onset neurological phenotype of the X-ALD gene inactivation in mice: a mouse model for adrenomyeloneuropathy. Hum. Mol. Genet. 2002; 11: 499–505
   PubMed Web of Science ®Google Scholar
• Raucy J. L., Lasker J., Ozaki K., Zoleta V. Regulation of CYP2E1 by ethanol and palmitic acid and CYP4A11 by clofibrate in primary cultures of human hepatocytes. Toxicol. Sci. 2004; 79: 233–241
   PubMed Web of Science ®Google Scholar
• Reddy J. K., Mannaerts G. P. Peroxisomal lipid metabolism. Annu. Rev. Nutr. 1994; 14: 343–370
   PubMed Web of Science ®Google Scholar
• Rieger M. A., Ebner R., Bell D. R., Kiessling A., Rohayem J., Schmitz M., Temme A., Rieber E. P., Weigle B. Identification of a novel mammary-restricted cytochrome P450, CYP4Z1, with overexpression in breast carcinoma. Cancer Res. 2004; 64: 2357–2364
   PubMed Web of Science ®Google Scholar
• Rietjens I. M. C. M., Soffers A. E. M. F., Veeger C., Vervoort J. Regioselectivity of cytochrome P-450 catalyzed hydroxylation of fluorobenzenes predicted by calculated frontier orbital substrate characteristics. Biochemistry. 1993; 32: 4801–4812
   PubMed Web of Science ®Google Scholar
• Sanders R. J., Ofman R., Duran M., Kemp S., Wanders R. J. Omega-oxidation of very long-chain fatty acids in human liver microsomes: Implications for X-linked adrenoleukodystrophy. J. Biol. Chem. 2006; 281: 13180–13187
   PubMed Web of Science ®Google Scholar
• Satarug S., Baker J. R., Urbenjapol S., Haswell-Elkins M., Reilly P. E., Williams D. J., Moore M. R. A global perspective on cadmium pollution and toxicity in non-occupationally exposed population. Toxicol. Lett. 2003; 137: 65–83
   PubMed Web of Science ®Google Scholar
• Savas U., Hsu M. H., Griffin K. J., Bell D. R., Johnson E. F. Conditional regulation of the human CYP4X1 and CYP4Z1 genes. Arch. Biochem. Biophys. 2005; 436: 377–385
   PubMed Web of Science ®Google Scholar
• Savas U., Hsu M. H., Johnson E. F. Differential regulation of human CYP4A genes by peroxisome proliferators and dexamethasone. Arch. Biochem. Biophys. 2003; 409: 212–220
   PubMed Web of Science ®Google Scholar
• Shan M., Dong B., Zhao X., Wang J., Li G., Yang Y., Li Y. Novel mutations in the CYP4V2 gene associated with Bietti crystalline corneoretinal dystrophy. Mol. Vis. 2005; 11: 738–743
   PubMed Web of Science ®Google Scholar
• Shimomura I., Shimano H., Horton J. D., Goldstein J. L., Brown M. S. Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells. J. Clin. Invest. 1997; 99: 838–845
   PubMed Web of Science ®Google Scholar
• Sontag T. J., Parker R. S. Comparative influence of major structural features of tocopherols and tocotrienols on kinetics of their omega-oxidation by cellular and microsomal tocopherol-omega -hydroxylase. J. Lipid Res. 2007; 48: 1090–1098
   PubMed Web of Science ®Google Scholar
• Sontag T. J., Parker R. S. Cytochrome P450 omega-hydroxylase pathway of tocopherol catabolism. Novel mechanism of regulation of vitamin E status. J. Biol. Chem. 2002; 277: 25290–25296
   PubMed Web of Science ®Google Scholar
• Stark K., Torma H., Cristea M., Oliw H. Expression of CYP4F8 (prostaglandin H 19-hydroxylase) in human epithelia and prominent induction in epidermis of psoriatic lesions. Arch. Biochem. Biophys. 2003; 409: 188–196
   PubMed Web of Science ®Google Scholar
• Stark K., Torma H., Oliw E. H. Co-localization of COX-2, CYP4F8, and mPGES-1 in epidermis with prominent expression of CYP4F8 mRNA in psoriatic lesions. Prostaglandins Other Lipid Mediat. 2006; 79: 114–125
   PubMed Web of Science ®Google Scholar
• Stec D. E., Roman R. J., Flasch A., Rieder M. J. A functional polymorphism in human CYP4F2 decreases 20-HETE production. Physiol Genomics. March 6, 2007
   PubMed Web of Science ®Google Scholar
• Takeuchi K., Renic M., Bohman Q. C., Harder D. R., Miyata N., Roman R. J. Reversal of delayed vasospasm by an inhibitor of the synthesis of 20-HETE. Am. J. Physiol Heart Circ. Physiol. 2005; 289: H2203–H2211
   PubMed Web of Science ®Google Scholar
• Wada Y., Itabashi T., Sato H., Kawamura M., Tada A., Tamai M. Screening for mutations in CYP4V2 gene in Japanese patients with Bietti's crystalline corneoretinal dystrophy. Am. J. Ophthalmol. 2005; 139: 894–899
   PubMed Web of Science ®Google Scholar
• Wang M. Z., Saulter J. Y., Usuki E., Cheung Y. L., Hall M., Bridges A. S., Loewen G., Parkinson O. T., Stephens C. E., Allen J. L., Zeldin D. C., Boykin D. W., Tidwell R. R., Parkinson A., Paine M. F., Hall J. E. CYP4F enzymes are the major enzymes in human liver microsomes that catalyze the O-demethylation of the antiparasitic prodrug DB289 [2,5-bis(4-amidinophenyl)furan-bis-O-methylamidoxime]. Drug Metabol Dispos. 2006; 34: 1985–1994
   PubMed Web of Science ®Google Scholar
• Williams D. E., Hale S. E., Okita R. T., Masters B. S. S. A prostaglandin omega-hydroxylase cytochrome P-450 (P-450 PG-omega) purified from lungs of pregnant rabbits. J. Biol. Chem. 1984; 259: 14600–14608
   PubMed Web of Science ®Google Scholar
• Xu F., Falck J. R., Ortiz de Montellano P. R., Kroetz D. L. Catalytic activity and isoform-specific inhibition of rat cytochrome p450 4F enzymes. J. Pharmacol. Exp. Ther. 2004; 308: 887–895
   PubMed Web of Science ®Google Scholar
• Xu F., Ng V. Y., Kroetz D. L., de Montellano P. R. CYP4 isoform specificity in the omega-hydroxylation of phytanic acid, a potential route to elimination of the causative agent of Refsum's disease. J. Pharmacol. Exp. Ther. 2006; 318: 835–839
   PubMed Web of Science ®Google Scholar
• Yamaguchi Y., Kirita S., Hasegawa H., Aoyama J., Imaoka S., Minamiyama S., Funae Y., Baba T., Matsubara T. Contribution of CYP4A8 to the formation of 20hydroxyeicosatetraenoic acid from arachidonic acid in rat kidney. Drug Metab Pharmacokinet. 2002; 17: 109–116
   PubMedGoogle Scholar
• Zhang J. Y., Wang Y., Prakash C. Xenobiotic-metabolizing enzymes in human lung. Curr. Drug Metabol. 2006; 7: 939–948
   PubMed Web of Science ®Google Scholar
• Zhang X., Chen L., Hardwick J. P. Promoter activity and regulation of the CYP4F2 leukotriene B(4) omega-hydroxylase gene by peroxisomal proliferators and retinoic acid in HepG2 cells. Arch. Biochem. Biophys. 2000; 378: 364–376
   PubMed Web of Science ®Google Scholar
• Zhang X., Hardwick J. P. Regulation of CYP4F2 leukotriene B(4) omega-hydroxylase by retinoic acids in HepG2 Cells. Biochem. Biophys. Res. Commun. 2000; 279: 864–871
   PubMed Web of Science ®Google Scholar
• Zheng Y. M., Fisher M. B., Yokotani N., Fujii-Kuriyama Y., Rettie A. E. Identification of a Meander Region Proline Residue Critical for Heme Binding to Cytochrome P450: Implications for the Catalytic Function of Human CYP4B1. Biochemistry. 1998; 37: 12847–12851
   PubMed Web of Science ®Google Scholar